Sale!

TUBA1A Gene Lissencephaly Type 3 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The TUBA1A Gene Lissencephaly Type 3 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the TUBA1A gene responsible for lissencephaly type 3, a severe brain malformation disorder. This comprehensive test utilizes Next Generation Sequencing (NGS) technology to detect genetic variations that cause abnormal brain development, characterized by a smooth brain surface lacking normal folds and grooves. The test is crucial for infants and children presenting with developmental delays, seizures, intellectual disability, and characteristic facial features. Results provide definitive diagnosis, enabling appropriate medical management, treatment planning, and genetic counseling for family members. The test is priced at $500 USD with a regular price of $700 USD, offering significant savings for comprehensive genetic analysis.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

TUBA1A Gene Lissencephaly Type 3 NGS Genetic DNA Test

Comprehensive Genetic Testing for Brain Malformation Disorders

The TUBA1A Gene Lissencephaly Type 3 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations responsible for lissencephaly type 3. This advanced testing methodology provides critical insights for families and healthcare providers managing complex brain development disorders.

What is TUBA1A Gene Lissencephaly Type 3?

Lissencephaly type 3 is a rare neurological condition characterized by abnormal brain development where the cerebral cortex appears smooth rather than having the typical folded appearance. The TUBA1A gene plays a crucial role in neuronal migration during fetal brain development, and mutations in this gene disrupt normal cortical formation, leading to severe neurological impairments.

What the Test Measures and Detects

Our advanced NGS (Next Generation Sequencing) technology comprehensively analyzes the TUBA1A gene to identify:

  • Point mutations and single nucleotide variants
  • Small insertions and deletions
  • Missense mutations affecting protein function
  • Pathogenic variants associated with lissencephaly spectrum disorders
  • Novel genetic variations with clinical significance

The test provides high-resolution genetic data that enables precise diagnosis and classification of lissencephaly type 3, distinguishing it from other forms of cortical malformations.

Who Should Consider This Test

Clinical Indications and Symptoms

This genetic test is recommended for individuals presenting with:

  • Infants with developmental delays and neurological abnormalities
  • Children exhibiting seizure disorders of unknown origin
  • Patients with intellectual disability and motor impairment
  • Individuals with characteristic facial features including microcephaly
  • Family history of lissencephaly or related brain malformations
  • Unexplained cerebral palsy-like symptoms
  • Abnormal brain imaging showing smooth brain surface
  • Feeding difficulties and growth retardation in infancy

Benefits of Taking the TUBA1A Genetic Test

Comprehensive Diagnostic Advantages

  • Definitive Diagnosis: Provides conclusive genetic evidence for lissencephaly type 3
  • Treatment Guidance: Informs appropriate medical management and therapeutic interventions
  • Prognostic Information: Helps predict disease progression and potential complications
  • Family Planning: Enables genetic counseling for future pregnancies
  • Early Intervention: Facilitates timely implementation of supportive therapies
  • Research Contribution: Advances understanding of rare neurological disorders

Understanding Your Test Results

Interpretation and Clinical Implications

Our comprehensive genetic report includes detailed analysis and interpretation:

  • Positive Result: Identification of pathogenic TUBA1A mutation confirms lissencephaly type 3 diagnosis
  • Negative Result: No mutation detected suggests alternative diagnoses should be considered
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • Carrier Status: Important for family members and reproductive planning

All results are accompanied by detailed genetic counseling recommendations and clinical management guidance from our expert team of genetic specialists.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Pre-Test Requirements

Before testing, we recommend:

  • Complete clinical history of the patient
  • Genetic counseling session to create family pedigree chart
  • Documentation of affected family members with TUBA1A-related conditions
  • Review of previous neurological evaluations and imaging studies

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services for families throughout the country.

Take the Next Step Toward Diagnosis

Don’t let uncertainty about neurological symptoms delay proper diagnosis and treatment. Our TUBA1A Gene Lissencephaly Type 3 NGS Genetic DNA Test provides the clarity needed for effective medical management and family planning decisions.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take control of your neurological health journey.

Our team of genetic counselors and pediatric neurologists are ready to provide comprehensive support throughout the testing process, from initial consultation to result interpretation and long-term management planning.